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Background:  Although vagal nerve stimulation (VNS) in the acute phase of AMI has a powerful anti-ischemic effect, technical difficulties 
associated with VNS preclude its application under emergency clinical settings. Furthermore, how the acute phase VNS translates into the 
long term benefit remains unknown. In this study, we developed intravenous VNS (iVNS), and evaluated how the short term iVNS for AMI 
impacts on the infarction size and cardiac function in the long term.
methods:  In mongrel dogs, we ligated the left anterior descending coronary artery for 3 hours and then reperfused (I/R). We delivered 
iVNS by an electrode catheter placed in the superior vena cava from the onset of ischemia to 1 hour after reperfusion.
results:  iVNS significantly lowered HR (105±19 vs. 163±4 bpm, p<0.05), while did not change blood pressure. At one month after I/R, 
iVNS strikingly decreased the infarct size more than 80% (Figure), lowered LVEDP (4.4±3.0 vs. 15.8±7.6 mmHg, p<0.05), and increased 
end-systolic elastance (Ees, sonomicrometric volumetry) (15.4±5.9 vs. 7.4±3.4 mmHg/ml, p<0.05) as well as LV ejection fraction 
(echocardiography) (60.8±3.1 vs. 48.6±6.5 %, p<0.05), suggesting that iVNS preserved LV systolic function.
conclusion:  Intravenous VNS for AMI is capable of reducing the infarct size and improving cardiac function in the long term. We conclude 
that iVNS is a new strategy for AMI to prevent chronic heart failure.
 
